Icon plc Stock
€290.80
Your prediction
Icon plc Stock
Pros and Cons of Icon plc in the next few years
Pros
Cons
Performance of Icon plc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Icon plc | -1.590% | -0.683% | 7.505% | 47.652% | 12.495% | - | - |
Alkermes plc | - | -1.786% | -0.901% | -21.429% | -12.000% | 24.294% | -1.786% |
Ironwood Pharmaceuticals | -2.520% | -7.200% | -21.088% | -39.896% | -43.137% | -41.117% | - |
Novocure Ltd | 8.700% | 32.158% | 78.326% | -72.485% | 41.786% | -86.061% | - |
Comments
News
ICON plc to hold Investor Day Meeting on May 30, 2024
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will hold an Investor Day which will take place on Thursday, May 30
ICON releases its ICON Cares 2023 Report
ICON plc, (NASDAQ:ICLR) a world-leading healthcare intelligence and clinical research organisation, today releases its ICON Cares 2023 Report. This outlines how the company is delivering on its
ICON Announces Pricing of USD 2 Billion Notes
ICON plc (NASDAQ: ICLR) (“ICON”), a world-leading healthcare intelligence and clinical research organization, today announced the pricing of a USD 2 billion SEC-registered bond offering, consisting